Neoleukin Therapeutics, Inc. (NLTX) Q4 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Neurogene Inc..

Watch the replay

Replay transcript excerpt

[Speaker identities could not be resolved; generic labels used] [00:00] Speaker 1: Good afternoon and thank you for joining us today for Neolucan Therapeutics Conference Call. [00:04] Speaker 1: At this time, all participants are in listen-only mode. [00:08] Speaker 1: Following the conclusion of the prepared remarks, we will conduct a question and answer session and instructions will follow at that time. [00:15] Speaker 1: As a reminder, today's conference call is being recorded. [00:18] Speaker 1: I would now like to turn the call over to Julie Rothman, Communications for Neolucan Therapeutics. Julie, please go ahead. [00:25] Speaker 2: Thank you. Good afternoon and welcome to Neolucan Therapeutics year-end 2021 [00:30] Speaker 2: conference call. Joining me on the call today from Neolucan are Jonathan Drockman, CEO, [00:35] Speaker 2: Priti Patel, CMO, [00:37] Speaker 2: and Sean Smith, Vice President, Finance. [00:40] Speaker 2: Today's call is being recorded. It will be available for replay on the Investor Relations section of the Neolucan website approximately 2 hours after the call for at least 30 days. [00:50] Speaker 2: Before we start, I'd like to remind you that today's call will include forward-looking statements based on current expectations. [00:56] Speaker 2: Such statements represent management's judgments, intentions, beliefs, and expectations about future events, [01:02] Speaker 2: strategies, product candidates, and operating plans. All forward-looking statements [01:07] Speaker 2: included in this presentation are made as of today and involve assumptions, risks, and uncertainties, [01:13] Speaker 2: and actual results could differ materially from those anticipated in the forward-looking statements. [01:18] Speaker 2: Neolucan undertakes no obligat...